SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Beam Therapeutics Q1 EPS $(1.030) Misses $(0.520) Estimate

Beam Therapeutics (NASDAQ:BEAM) reported quarterly losses of $(1.030) per share which missed the analyst consensus estimate of $(0.520) by 98.08 percent.

Benzinga · 05/12/2020 10:34

Beam Therapeutics (NASDAQ:BEAM) reported quarterly losses of $(1.030) per share which missed the analyst consensus estimate of $(0.520) by 98.08 percent.